Radiation therapy can treat certain difficult heart rhythm problems, particularly ventricular tachycardia that has not responded to medicines or conventional procedures. The technique is called stereotactic arrhythmia radioablation (STAR). It uses highly focused radiation beams to target the part of the heart responsible for the abnormal rhythm without making an incision or inserting a catheter during treatment. Although early results are encouraging, it remains a specialized treatment with ongoing research into its long-term benefits and risks.
Can radiation therapy treat an abnormal heart rhythm?
Yes. Doctors can use a specialized form of radiation therapy to treat selected cases of ventricular arrhythmia, especially recurrent ventricular tachycardia (VT). This condition occurs when the lower chambers of the heart develop an abnormally fast rhythm that can interfere with the heart's ability to pump blood.
Unlike conventional radiation therapy, which is commonly used to treat cancer, cardiac radioablation directs radiation toward a specific area of heart muscle associated with abnormal electrical signals.
The treatment is also known by several names:
- Stereotactic arrhythmia radioablation (STAR): A commonly used name for this specialized treatment.
- Cardiac radioablation: Describes the use of focused radiation to target abnormal electrical pathways in the heart.
- Stereotactic body radiation therapy (SBRT): The radiation technique used to deliver a concentrated dose to the targeted heart tissue.
STAR is not a general treatment for every type of arrhythmia. Most clinical research has focused on people with difficult-to-control ventricular tachycardia, often associated with previous heart damage or scar tissue. Evidence for using radiation to treat atrial fibrillation and other rhythm disorders remains limited.
Which types of arrhythmia may be treated with radiation?
The main condition being studied for cardiac radioablation is recurrent ventricular tachycardia. In many affected patients, abnormal electrical signals travel through areas of damaged heart muscle and repeatedly trigger rapid heartbeats.
Ventricular tachycardia
Ventricular tachycardia begins in the lower chambers of the heart. It may occur in people with previous heart attacks, cardiomyopathy, or other conditions that have damaged the heart muscle.
Some people experience repeated episodes despite taking antiarrhythmic medicines and undergoing catheter ablation. These episodes may require emergency treatment or lead to repeated shocks from an implantable cardioverter-defibrillator (ICD).
Radiation therapy is being investigated as another way to reach the abnormal electrical circuits, particularly when conventional catheter procedures have not controlled the rhythm or cannot safely reach the target.
Atrial fibrillation
Atrial fibrillation (AF) is an irregular rhythm that begins in the upper chambers of the heart. Although radiation-based treatment has been explored in a small number of patients, it has not become an established alternative to conventional AF treatments.
Catheter ablation and appropriate medication remain the usual treatment approaches for selected people with atrial fibrillation.
Other ventricular rhythm disorders
Small numbers of patients with other ventricular rhythm problems, including frequent premature ventricular contractions (PVCs) and ventricular fibrillation, have been described in early research. However, these applications do not have the same level of supporting evidence as the investigation of difficult-to-control ventricular tachycardia.
When might a person be considered for radiation therapy?
Cardiac radioablation is generally considered when a person's ventricular tachycardia remains difficult to control despite conventional treatment.
Potential candidates may have one or more of the following circumstances:
- Repeated ventricular tachycardia despite appropriate antiarrhythmic medication.
- Recurrence of the abnormal rhythm after one or more catheter ablation procedures.
- Electrical storm, which involves repeated episodes of dangerous ventricular arrhythmia over a short period.
- Heart muscle scar that is difficult to reach with conventional catheter techniques.
- Mechanical heart valves or other anatomical problems that make catheter access difficult.
- Medical conditions that make another invasive procedure particularly challenging.
Having one of these circumstances does not automatically mean radiation therapy is appropriate. The treatment target must be identifiable, and the possible benefit must be considered alongside the person's overall heart function and medical condition.
The joint clinical consensus statement from the European Heart Rhythm Association (EHRA), European Society of Cardiology (ESC), and Heart Rhythm Society (HRS) recommends considering STAR within an approved investigational trial for selected patients whose ventricular tachycardia remains uncontrolled despite antiarrhythmic medication and catheter ablation at an experienced centre.
These recommendations reflect the need for careful patient selection rather than routine use of radiation for all recurrent arrhythmias. The EHRA and HRS clinical consensus statement provides detailed guidance on eligibility, treatment planning, and follow-up.
What are the treatment options for difficult ventricular arrhythmia?
Radiation therapy is one potential option within a broader treatment plan. Most patients with ventricular tachycardia are initially managed using established approaches, depending on the underlying heart condition and the nature of the rhythm problem.
1. Antiarrhythmic medications
Medicines can help control abnormal electrical activity and reduce the frequency of ventricular tachycardia episodes. Depending on the situation, doctors may prescribe medications such as amiodarone or other antiarrhythmic drugs.
Some patients continue to experience episodes despite medication. Others may not tolerate the side effects or may have medical reasons that limit the available drug choices.
2. Catheter ablation
Catheter ablation is a procedure that uses thin, flexible tubes inserted through blood vessels to reach the heart. The specialist identifies the abnormal electrical pathway and applies energy, commonly radiofrequency energy, to create small areas of scar tissue that interrupt the abnormal signals.
Catheter ablation is an established treatment for selected patients with recurrent ventricular tachycardia. However, it may not completely eliminate the abnormal electrical circuits, particularly when these areas are deep within the heart muscle or difficult to access.
In some cases, repeat ablation or more advanced catheter techniques may be considered before radiation treatment.
3. Implantable cardioverter-defibrillator
An implantable cardioverter-defibrillator (ICD) is a device placed under the skin and connected to the heart through electrical leads or, in some device designs, placed without leads inside the heart.
It continuously monitors heart rhythm and can deliver electrical treatment when it detects a dangerous rhythm. An ICD can help prevent sudden cardiac death, but it does not necessarily remove the underlying cause of ventricular tachycardia.
People who undergo cardiac radioablation may still need their ICD and regular device monitoring.
4. Stereotactic arrhythmia radioablation
STAR may be considered when ventricular tachycardia continues despite other treatments or when conventional catheter ablation is unsuitable.
Rather than entering the heart with a catheter during treatment, the radiation team uses external equipment to direct focused radiation toward the identified area of abnormal electrical activity.
A 2024 review in the Journal of Medical Imaging and Radiation Oncology describes STAR as a non-invasive approach being investigated for ventricular arrhythmias that remain difficult to control with conventional procedures.
How does radiation therapy for arrhythmia work?
STAR uses advanced imaging, electrical heart mapping, and radiation planning to identify and target the area responsible for the abnormal rhythm.
Step 1: Identifying the abnormal electrical pathway
Before treatment, the cardiology team investigates where the ventricular tachycardia originates and which areas of heart muscle may be involved.
Doctors may use information from previous electrophysiology procedures, electrical mapping, cardiac CT, or cardiac MRI. These investigations help identify the abnormal tissue and understand its relationship with nearby heart structures.
Step 2: Planning the radiation treatment
Radiation oncologists and medical physicists use the available heart images and electrical mapping information to create a treatment plan.
The plan identifies the target area and calculates how radiation beams should be directed. Particular attention is given to nearby structures, including healthy heart muscle, heart valves, coronary arteries, lungs, and the esophagus.
Step 3: Delivering focused radiation
During treatment, the patient lies on a treatment table while a specialized radiation machine delivers beams from different directions. The beams meet at the planned target, allowing a concentrated dose to reach the selected heart tissue.
The procedure does not require an incision or a catheter to be placed inside the heart during radiation delivery. The patient is positioned carefully, and the radiation team uses imaging and monitoring to help ensure accurate treatment.
Most published STAR treatment protocols have used a single radiation session, often around 25 Gy. However, the exact dose and treatment plan may differ according to the patient's anatomy, target location, and the centre's protocol.
The STOPSTORM.eu consortium's treatment-planning research, published in 2025, found that participating centres commonly used a single-fraction 25 Gy prescription. It also identified differences in planning methods and areas where further agreement on dose limits is needed. The STOPSTORM.eu treatment-planning study describes these technical considerations.
What results can patients expect from radiation therapy?
Early clinical research suggests that STAR can reduce the number of ventricular tachycardia episodes and ICD shocks in some people with difficult-to-control arrhythmia. However, a reduction in episodes does not necessarily mean that the abnormal rhythm has disappeared permanently.
One of the most important recent sources of information is the prospective STOPSTORM.eu registry study, published in the European Heart Journal on October 14, 2026.
The study included 193 patients treated at 28 European centres. Among 107 patients with at least six months of evaluable follow-up, the median number of ventricular tachycardia episodes was reduced by 80% compared with the six months before treatment.
Among the evaluable patients in the shock analysis, 72% were free from ICD shocks after treatment. However, ventricular tachycardia recurred at some point during follow-up in 106 of the 193 patients. These findings show that the treatment may substantially reduce arrhythmia activity without reliably eliminating it.
The 2026 STOPSTORM.eu study in the European Heart Journal provides encouraging multicentre results, while also highlighting the continuing problem of recurrent arrhythmia.
What does the wider research show?
A 2026 systematic review and meta-analysis published in the journal Heart assessed 215 patients across 22 studies. The researchers reported an average reduction of 81.5% in ventricular tachycardia episodes per month and an 84.7% reduction in ICD shocks per month.
However, only 23.1% of patients were free from ventricular tachycardia at the end of follow-up. The researchers also reported adverse events, although only a proportion were considered likely to be related to STAR itself.
This distinction is important because many patients receiving this treatment have advanced heart disease and other serious medical problems. Not every complication or death occurring after treatment is necessarily caused by radiation.
The 2026 systematic review in Heart supports the possibility of meaningful reductions in arrhythmia episodes and ICD shocks, but also emphasizes the need for better long-term safety and effectiveness data.
What are the possible side effects and risks?
Although cardiac radioablation avoids some risks associated with invasive heart procedures, it still exposes heart tissue and potentially nearby organs to a high dose of radiation.
Possible short-term effects include:
- Fatigue or unusual tiredness.
- Dizziness.
- Nausea.
- Low blood pressure.
- Temporary discomfort or other symptoms following treatment.
Some complications may appear later rather than immediately. Depending on the radiation target and the structures nearby, reported concerns include:
- Pericarditis: Inflammation of the thin covering around the heart.
- Pericardial effusion: A buildup of fluid around the heart.
- Pneumonitis: Inflammation of lung tissue that may cause breathing symptoms.
- Heart valve damage: Radiation exposure may affect nearby heart valves.
- Esophageal injury: Damage to the food pipe is a rare but potentially serious complication when it receives radiation exposure.
- Worsening heart function: Heart failure may worsen in some patients, although it can be difficult to separate treatment-related effects from the progression of existing heart disease.
Another consideration is the possible effect of radiation on an implanted pacemaker or defibrillator. The radiation team must account for the device and its leads when developing the treatment plan. Device function may need to be checked during and after treatment.
The full long-term safety profile remains uncertain because the number of treated patients is relatively small and follow-up periods are still limited. Potential late damage to the coronary arteries, heart valves, and other surrounding structures is an important area of ongoing research.
What happens after radiation treatment?
Completing radiation treatment does not mean that monitoring is no longer necessary. Patients usually need continued follow-up with their cardiologist and electrophysiology team.
Doctors may monitor several aspects of heart health:
- Heart rhythm: Electrocardiograms (ECGs) and other rhythm tests can help identify ongoing or recurrent ventricular arrhythmia.
- ICD activity: Device checks help determine whether further episodes have occurred and whether electrical treatments or shocks have been delivered.
- Heart function: Echocardiography may be used to assess pumping function and look for changes in heart valves or other structures.
- Possible radiation effects: Follow-up visits help identify early and delayed complications involving the heart or nearby organs.
- Medication needs: Antiarrhythmic medicines may need to continue, and any changes should be guided by the treating cardiologist.
Some patients continue to experience ventricular tachycardia after treatment. Radiation does not always produce an immediate change in the abnormal electrical activity, and the response may develop over time.
New or worsening symptoms, including fainting, chest discomfort, breathlessness, or repeated ICD shocks, should be reported promptly. Repeated ICD shocks, fainting, or persistent chest pain require urgent medical assessment.
How does radiation therapy compare with catheter ablation?
Both treatments aim to reduce abnormal electrical activity, but they use different methods to reach the target.
| Feature | Radiation therapy (STAR) | Catheter ablation |
|---|---|---|
| Method | Focused external radiation beams | Energy delivered through a catheter inside or around the heart |
| Need for an incision | No incision is needed for radiation delivery | Requires vascular access, usually through a blood vessel |
| Target identification | Uses heart imaging and electrical mapping information | Uses electrophysiology mapping during the procedure |
| Treatment sessions | Usually delivered in one session in established STAR protocols | Depends on the procedure and clinical situation |
| Evidence and availability | Emerging treatment with limited long-term evidence | Established treatment for selected arrhythmias |
| Potential limitations | Long-term radiation effects and incomplete rhythm control remain concerns | Some abnormal pathways may be difficult to reach or eliminate |
Neither approach is appropriate for every patient. Catheter ablation remains an established treatment, while radiation therapy may offer another possibility for carefully selected people whose ventricular tachycardia is particularly difficult to manage.
What should patients discuss with their heart specialist?
Anyone being considered for cardiac radioablation should have an individualized discussion involving an experienced electrophysiologist and radiation oncologist. A heart failure specialist and cardiac imaging specialist may also contribute to the assessment.
Useful questions to ask include:
- Is the abnormal rhythm coming from an area that can be identified and safely targeted?
- Have appropriate medication and catheter treatment options been considered?
- Is radiation therapy available through an approved clinical trial or specialized programme?
- What benefits are realistic given the current condition of the heart?
- Could radiation affect nearby valves, coronary arteries, lungs, or the esophagus?
- Will the ICD or pacemaker require special precautions?
- What follow-up tests and long-term monitoring will be needed?
The answers help patients and families understand whether the potential benefits justify the risks and uncertainties of this developing treatment.